Ivan Pires News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIT Professor Darrell Irvine describes a novel vaccine adjuvant: a nanoparticle that can help stimulate the immune system to generate a stronger response to a vaccine. An HIV vaccine with this adjuvant will be tested in clinical trials.

MIT Koch Institute researchers develop a cancer treatment combining immune checkpoint blockade therapy with STING. The resulting vaccine eliminates most tumors and prevents recurrence in mice, with minimal side effects.